NCT06730165

Brief Summary

The aim of this study was to compare the results between transcutaneous auricular vagus nerve stimulation and trigeminal nerve stimulation with the results obtained from heart rate variability, pulse and blood pressure measurements and to reveal which method is more effective in autonomic nervous system neuromodulation. Hypotheses of the study: H0: Vagus nerve stimulation is more effective than trigeminal nerve simulation in terms of heart rate variability. H1: Trigeminal nerve stimulation is more effective than vagus nerve simulation in terms of heart rate variability.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 3, 2024

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 10, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 22, 2024

Completed
20 days until next milestone

First Posted

Study publicly available on registry

December 12, 2024

Completed
Last Updated

December 12, 2024

Status Verified

December 1, 2024

Enrollment Period

29 days

First QC Date

November 22, 2024

Last Update Submit

December 11, 2024

Conditions

Keywords

Vagus Nerve StimulationsTrigeminal Nerve Stimulations

Outcome Measures

Primary Outcomes (1)

  • Heart Rate Variability

    5 minutes of heart rate variability was measured.

    Pre-intervention and immediately after the intervention

Secondary Outcomes (1)

  • Systolic and Diastolic Blood Pressure

    Pre-intervention and immediately after the intervention

Study Arms (4)

Transcutaneous Auricular Vagus Nerve Stimulation

ACTIVE COMPARATOR

Transcutaneous vagus nerve stimulation through the tragus and concha in the ear, Frequency: 25 Hertz, Duration: 20 minutes

Device: Transcutaneous Auricular Vagus Nerve Stimulation

Transcutaneous Auricular Trigeminal Nerve Stimulation

ACTIVE COMPARATOR

Transcutaneous auricular trigeminal nerve stimulation, Frequency: 25 Hertz, Duration: 20 minutes

Device: Transcutaneous Auricular Trigeminal Nerve Stimulation

Sham Transcutaneous Auricular Vagus Nerve Stimulation

SHAM COMPARATOR

Sham Transcutaneous Auricular Vagus Nerve Stimulation, The device is switched on but the current intensity is off, Duration: 20 minutes

Device: Transcutaneous Auricular Vagus Nerve Stimulation

Sham Transcutaneous Auricular Trigeminal Nerve Stimulation

SHAM COMPARATOR

Sham Transcutaneous Auricular Trigeminal Nerve Stimulation, The device is switched on but the current intensity is off, Duration: 20 minutes

Device: Transcutaneous Auricular Trigeminal Nerve Stimulation

Interventions

Stimulation of the vagus nerve through the tragus and concha in the ear

Sham Transcutaneous Auricular Vagus Nerve StimulationTranscutaneous Auricular Vagus Nerve Stimulation

Stimulation of the trigeminal nerve via the auriculotemporal nerve with a clip electrode from the upper auricle

Sham Transcutaneous Auricular Trigeminal Nerve StimulationTranscutaneous Auricular Trigeminal Nerve Stimulation

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • To be 18 years of age or older,
  • Not having any acute or chronic disease.

You may not qualify if:

  • Having any acute or chronic disease,
  • Having previously undergone vagus nerve stimulation or trigeminal nerve stimulation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Avrasya University

Trabzon, Ortahisar, 61000, Turkey (Türkiye)

Location

Related Publications (4)

  • Wang Y, Li SY, Wang D, Wu MZ, He JK, Zhang JL, Zhao B, Hou LW, Wang JY, Wang L, Wang YF, Zhang Y, Zhang ZX, Rong PJ. Transcutaneous Auricular Vagus Nerve Stimulation: From Concept to Application. Neurosci Bull. 2021 Jun;37(6):853-862. doi: 10.1007/s12264-020-00619-y. Epub 2020 Dec 23.

    PMID: 33355897BACKGROUND
  • Ben-Menachem E, Revesz D, Simon BJ, Silberstein S. Surgically implanted and non-invasive vagus nerve stimulation: a review of efficacy, safety and tolerability. Eur J Neurol. 2015 Sep;22(9):1260-8. doi: 10.1111/ene.12629. Epub 2015 Jan 23.

    PMID: 25614179BACKGROUND
  • Milby AH, Halpern CH, Baltuch GH. Vagus nerve stimulation for epilepsy and depression. Neurotherapeutics. 2008 Jan;5(1):75-85. doi: 10.1016/j.nurt.2007.10.071.

    PMID: 18164486BACKGROUND
  • Percin A, Ozden AV, Yenisehir S, Albayrak HE. Autonomic Effects of Transcutaneous Auricular Vagus and Trigeminal Nerve Stimulation: A Randomized, Sham-Controlled, and Single-Blind Study. Neuromodulation. 2025 Oct 27:S1094-7159(25)01038-4. doi: 10.1016/j.neurom.2025.09.312. Online ahead of print.

Study Officials

  • Yavuz Ozoran, Prof.

    Dean of the Health Sciences Faculty

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SCREENING
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asst. Prof.

Study Record Dates

First Submitted

November 22, 2024

First Posted

December 12, 2024

Study Start

March 3, 2024

Primary Completion

April 1, 2024

Study Completion

September 10, 2024

Last Updated

December 12, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations